Incorporating Patient Use-Phase Emissions into Holistic LCAs In the increasingly complex landscape of pharmaceutical manufacturing and environmental compliance, Life Cycle Assessment (LCA) emerges as a critical tool. This comprehensive process evaluates the environmental impact of a product from its inception to its disposal, commonly characterized as a “cradle-to-grave” approach. As the industry pivots towards sustainability, it is imperative for professionals involved in regulatory affairs, clinical operations, and medical affairs to aptly incorporate patient use-phase emissions into their LCAs to ensure conformity with U.S. Food and Drug Administration (FDA) expectations and to mitigate environmental risks effectively. Understanding Life Cycle Assessment (LCA)…

Digitalisation and Automation of LCA Workflows in Large Portfolios In response to increasing regulatory scrutiny and consumer demand for sustainable practices, pharmaceutical companies are increasingly focusing on life cycle assessment (LCA) and environmental risk assessment (ERA) for their products. Given the complex landscape of regulations enforced by the FDA and other organizations, this step-by-step tutorial will provide a comprehensive guide to digitalising and automating LCA workflows within large pharmaceutical portfolios. Understanding Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) Life Cycle Assessment (LCA) is a systematic analysis aimed at assessing the environmental impacts of a product throughout its entire…

Training scientists and regulatory teams on LCA and ERA concepts Training Scientists and Regulatory Teams on LCA and ERA Concepts In the evolving landscape of pharmaceutical manufacturing and regulatory compliance, the integration of sustainability practices has become essential. Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) are foundational tools that aid in understanding the environmental impacts of pharmaceutical products throughout their lifecycle. This tutorial is designed to guide pharma professionals, including those in clinical operations, regulatory affairs, and medical affairs, in mastering LCA and ERA concepts while ensuring compliance with FDA regulations. Understanding Life Cycle Assessment (LCA) Life Cycle…

Case studies of supplier sustainability programs in global pharma companies Case Studies of Supplier Sustainability Programs in Global Pharma Companies Introduction to Supplier Sustainability in Pharma In recent years, sustainability has emerged as a critical focus within the pharmaceutical industry. This emphasis is driven by both regulatory requirements and stakeholder expectations, particularly in light of increasing scrutiny on environmental, social, and governance (ESG) practices. Supplier sustainability audits play a pivotal role in ensuring that procurement policies align with corporate social responsibility (CSR) and sustainability goals. As pharmaceutical companies strive to enhance their environmental impact, engage in sustainable practices, and reduce…

Risk-based Segmentation of Suppliers for Sustainability and Compliance Focus Risk-based Segmentation of Suppliers for Sustainability and Compliance Focus in Pharma The pharmaceutical industry is increasingly under pressure to enhance sustainability practices while simultaneously ensuring compliance with regulatory standards. This article serves as a comprehensive tutorial for pharma professionals aiming to develop effective supplier sustainability audits and implement robust procurement policies aligned with green supply chain goals. The focus lies primarily on US regulations, with references to UK and EU expectations where applicable. Understanding the Regulatory Landscape To successfully navigate sustainability initiatives within the pharmaceutical sector, one needs to comprehend the…

How to Build a Green Supply Chain Strategy for APIs, Excipients, and Packaging In an increasingly competitive environment, pharmaceutical companies are under financial, social, and legal pressures to adopt sustainable practices throughout their operations. This need for sustainability extends to supply chain management, particularly for Active Pharmaceutical Ingredients (APIs), excipients, and packaging materials. A green supply chain strategy not only helps in achieving regulatory compliance but also enhances the corporate image, particularly in the context of Environmental, Social, and Governance (ESG) expectations. This article provides a step-by-step regulatory tutorial on how to develop a green supply chain strategy, emphasizing key…

Embedding ESG Criteria into Procurement Policies for FDA-Regulated Companies The increasing emphasis on environmental, social, and governance (ESG) factors has become a priority within the pharmaceutical industry. As FDA-regulated companies strive to align their procurement policies with sustainable practices, understanding how to effectively embed ESG criteria is crucial. This article provides a comprehensive, step-by-step tutorial on integrating ESG factors, focusing on supplier sustainability audits and the development of green supply chains. We will also examine relevant regulations to ensure compliance and enhance environmental stewardship. 1. Understanding ESG and Its Importance in Pharma ESG encompasses a set of standards that socially…

Designing Supplier Sustainability Audits for Pharma and Biotech Supply Chains Introduction to Supplier Sustainability in Pharma The pharmaceutical and biotech industries are increasingly recognizing the importance of sustainability in supply chain management. This trend is not only driven by regulatory requirements but also by a growing awareness of the need to address environmental, social, and governance (ESG) issues. Supplier sustainability audits are essential for ensuring that suppliers meet the necessary standards for compliance while contributing to the overall sustainability goals of the organization. Sustainable procurement policies are critical as they guide how companies engage with suppliers in a manner that…

Digital Tools and Platforms for Supplier ESG Data Collection and Analysis Introduction In the pharmaceutical industry, sustainability has become a crucial aspect of regulatory compliance and operational efficiency. As organizations strive to meet their environmental, social, and governance (ESG) performance objectives, implementing supplier sustainability audits is essential. This article will provide a comprehensive step-by-step guide to utilizing digital tools and platforms for collecting and analyzing data relevant to supplier ESG considerations. We will explore the significance of procurement policies in facilitating green supply chains, the role of digital supplier platforms in achieving net-zero targets, and effective strategies for managing scope…

Aligning Sourcing Decisions with Scope 3 Emissions and Net-Zero Targets in the Pharma Industry In recent years, there has been a growing focus on sustainability within the pharmaceutical industry, driven by the urgent need to address climate change and improve environmental, social, and governance (ESG) factors. One of the key responsibilities of pharmaceutical professionals involves understanding supplier sustainability audits and how these can be aligned with procurement policies to foster green supply chains. This article provides a comprehensive, step-by-step tutorial aimed at empowering pharma professionals in their journey towards integrating sustainability into their sourcing decisions, particularly addressing scope 3 emissions…